You are here
BOLDER BIOTECHNOLOGY INC
UEI: CJ6GFX2TU3J4
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Long-Acting VEGF Binding Proteins for Treating Cancer
Amount: $100,000.00DESCRIPTION (provided by applicant): Vascular endothelial growth factor (VEGF) has been identified as a key mediator of tumor angiogenesis and has emerged as the single most commonly upregulated ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Long-Acting Growth Hormone For HIV-Associated Wasting
Amount: $303,204.00DESCRIPTION (provided by applicant): Unintentional weight loss, or wasting, occurs in up to 30% of HIV patients and correlates with increased mortality, increased disease severity, decreased functiona ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Long Acting EPO For Treating Chronic Kidney Disease
Amount: $500,000.00DESCRIPTION (provided by applicant): Anemia is a frequent finding in patients with chronic kidney disease (CKD) and is present in over 90 percent of CKD patients with end-stage renal disease. Anemia t ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Long Acting VEGF Inhibitor for Treating RA
Amount: $100,000.00DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes progressive joint destruction, deformities and disability. One of the earliest observed ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Long-Acting IL-11 for Treating Thrombocytopenia
Amount: $863,245.00DESCRIPTION (provided by applicant): Interleukin 11 (IL-11) is a cytokine that stimulates proliferation, maturation and functional activation of platelets. Recombinant human IL- 11 is approved and mar ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Long-Acting IL-11 for Treating Thrombocytopenia
Amount: $0.00DESCRIPTION (provided by applicant): Interleukin 11 (IL-11) is a cytokine that stimulates proliferation, maturation and functional activation of platelets. Recombinant human IL- 11 is approved and mar ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
LONG-ACTING STABILIZED ANGIOSTATIN PROTEINS FOR CANCER
Amount: $100,000.00DESCRIPTION: Angiostatin is 38 kDa proteolytic internal fragment of plasminogen (kringles 1-4) and an endogenous inhibitor of angiogenesis and tumor growth. By inhibiting endothelial proliferation, an ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
LONG ACTING THROMBOPOIETIN FOR TREATING THROMBOCYTOPENIA
Amount: $111,802.00DESCRIPTION (provided by applicant): Thrombopoietin (TPO) is a cytokine that stimulates the proliferation and differentiation of megakaryocytes, the precursors to blood platelets. Recombinant human TP ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
CYTOKINE CONJUGATES FOR TREATING THROMBOCYTOPENIA
Amount: $798,378.00DESCRIPTION (provided by applicant): Most human protein therapeutics require frequent dosing due to rapid clearance of the proteins from the body. Development of second generation protein pharmaceutic ...
SBIRPhase II2002Department of Health and Human Services National Institutes of Health -
CYTOKINE CONJUGATES FOR TREATING THROMBOCYTOPENIA
Amount: $0.00DESCRIPTION (provided by applicant): Most human protein therapeutics require frequent dosing due to rapid clearance of the proteins from the body. Development of second generation protein pharmaceutic ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health
